Medicines Optimisation Team Standard Operating Procedure Insulin Quantities Audit
|
|
- Shonda Cain
- 5 years ago
- Views:
Transcription
1 Medicines Optimisation Team Standard Operating Procedure Insulin Quantities Audit Aim Review and rationalise the insulin quantities based on dosage instructions for diabetic patients in order to align quantities prescribed and reduce waste. Rationale The appropriate use of prescribed insulin is paramount since it has both patient safety and health economic implications. Incorrect or ambiguous dosage instructions can lead to adverse outcomes. Over ordering of insulin can cause unnecessary stock piling of medication in patient s homes that poses a risk to the individual and waste to the health economy. Inclusion criteria: All patients prescribed any insulin preparations as pens or insulin vials. Audit criteria Patient ID Patient surname Patient Forename Patient Age Registered or usual or prescribing GP [as per practice] Institutionalised or housebound status documented Current insulin, directions and quantity prescribed over the last 3 months Insulin initiated by Problem history of hypoglycaemia or hyperglycaemia Concurrent medication for hypoglycaemia, eg. Hypostop Gel and/or glucagon (GlucaGen Version I. August 2016 Page 1
2 HypoKit ) Diabetes Type documented (i.e. type 1 or 2, gestational, insulin pump) Pharmacist comments Proposed action GP agreement Exclusion Criteria Exclude patients who have had recent medication review and had prescribed quantities adjusted. Method Medicines Optimisation Lead for CCG will inform all GP practices within CCGs about the insulin quantities audit prior to its implementation Run the insulin search for your allocated surgery using the audit criteria above (Pre-built insulin search is available on EMIS enterprise to be copied where applicable) Export the results to EXCEL spread sheet Practice prescribing lead or equivalent to confirm all patients at the practice level on current insulin prescription and agrees to the audit Confirm the current insulin dose (from patients consultation notes, secondary care letters or by telephoning patient, this source should be documented in the consultation history with the date)/ On EMIS-web the READ code 66Aw (Insulin Dose) should be used to document the dosage. Calculate the required quantities using the current dose and insulin calculator provided, ensure there are enough for air shots Review the ordering frequency of the patient to ascertain whether over ordering is occurring Adjust the quantities on patient prescription and round it up to nearest whole pen. If the patient quantity needed per month when rounded up is very close to a full pen i.e. 0.8 or above it would be sensible to allow an extra pen in case of loss or malfunction. In addition set two pens as a minimum per month per patient, as one pen would be a risk for the reason stated above. Record the potential cost saving based on the previous 12 months issues of insulin. Inform the patient of any adjustments made via letter or verbally Note: Repeat dispensing patients should not be switched until the next authorised batch of prescriptions is due. However, if the GP practice has a robust recall process in place and the remaining batch prescription(s) are returned successfully, these patients may be switched. Identify the patient(s) on the data collection sheet with your recommendation(s) and discuss with the practice their preferred method of proceeding further. Version I. August 2016 Page 2
3 Worked example Method 1 calculation table (appendix 1) Patient is on 58 - Round up to 60 on the table. This would mean that 2016 would be needed per month which would be 6.72 pens and round up to 7 pens. As we have already rounded up the dose this quantity should be appropriate for this patient, but be cautious if rounding down e.g. if patient had been on 54 and we had gone to 50 you may want to give an additional pen. Method 2 Calculation from diabetes guidelines As a rule of thumb to calculate the quantity of insulin to prescribe the following formula can be used: (Total daily ) daily =58/10 = = 6.8 pens rounded up to 7 pens 54 daily =54/10= =6.4 pens rounded up to 7 pens (note if using table would come out as 6 pens) When all the above has been completed: Add a consultation to the patients notes to state the action taken Add the dose and the date this was confirmed in brackets to each of the insulin prescriptions if this is agreed with the practice, especially if currently only prescribed as directed. Mail merge and send patient letter if previously agreed. QIPP interventions captured and reported on QIPP record sheet. Adjusting insulin quantities: Once the above has been completed change the insulin quantities on the patients repeat prescription. If insulin quantities have been altered in consultation mode then add quantities altered with a brief explanation of changes carried out in the free text. Amend the medication duration on the prescription to coincide with how long this quantity of pens will last for the patient in-line with other prescription items. Informing the Patient: Informing the patient will depend on individual practice policies and the nature of the change. This may be done during the telephone conversation with the patient or by letter. Version I. August 2016 Page 3
4 Safety: If the person carrying out the changes has any concerns e.g. any alerts (such as do not change the quantity ) refer the query to the GP, practice pharmacist or Medicines Optimisation Team. Version I. August 2016 Page 4
5 APPENDIX 1 Quantity Calculation Chart Calculation Chart for the monthly amount of insulin to be prescribed in relation to daily dose taken Daily dose With air shots used when changing pen needles. Daily Number of used per month with airshots (Pens and cartridges) Number of 3ml cartridges or pens needed per monthly prescription (contain 300 ) Number of required per month with no airshot (Syringes) Number of10ml vials needed per monthly prescription (1,000 ). No airshot required. 1 will last 3 months Insulin calculation will be needed for each type of insulin being used At times of sickness, infection, pregnancy, steroid treatment more insulin will be required for that period. People with type 1 and type 2 diabetes who vary insulin dose with meals will need enough to cover the average amount taken each month Gluco RX needles are suitable for all devices. Lengths longer than 8 mm should not be used. Skin lifts are important to inject into the subcutaneous layer of skin. Version I. August 2016 Page 5
6 APPENDIX 2 Template patient letter Dear (Patient name) Date: Re: (Name of prescribed item, strength and form) Patients may have excessive quantities of prescription items that are ordered but are not always used before it is ordered again. This can lead to a build-up of unused prescribed items in your home, presenting a potential safety risk. Risks could include: Accidentally taking/using prescription items which are out of date. Accidentally taking/using the wrong prescription items. Increasing the chance of young children finding them. To reduce this risk, prevent medicines waste and to make best use of NHS resources, we have been reviewing the prescribing of some prescription items. We have reviewed the prescriptions of all patients who are prescribed (name of prescribed item, strength and form). The quantity of your (name of prescribed item, strength and form) has been changed from: Original quantity: (specify ORIGINAL quantity) to: New quantity: (specify NEW quantity) The maximum number of prescription issues before your next review date has been limited. Please note the reason for this alteration is NOT that your condition has changed. If you have any further queries, please discuss with your community pharmacist or GP. Yours sincerely, On behalf of Name of GP practice Version I. August 2016 Page 6
7 Version Date of review: Author: Approved by: Lilliana Alani, Specialist Clinical Audit Facilitator in MM, Cannock Chase CCG GP Lead South East Staffs & Seisdon CCG Head of Medicines Optimisation South East Staffs & Seisdon CCG Date of approval: 1/11/2016 Version I. August 2016 Page 7
Optimising Insulin Pen Needles
Optimising Insulin Pen Needles Following a review of insulin pen needles NHS Telford and Wrekin CCG now recommends the use of GlucoRx FinePoint Pen Needles. GlucoRx FinePoint Pen Needles are a high quality
More informationGuidance on Bulk Prescribing for Care Home Patients
Guidance on Bulk Prescribing for Care Home Patients Introduction Many patients in care homes taking medicines when required (PRN) can inevitably present problems for the prescriber in determining the quantity
More informationFencino patch (5) 2. Check the practice has agreed to the protocol and a signed copy is in place.
Switch protocol: Fentanyl/Durogesic patches to Fencino /Matrifen /Mezolar brand switch Applies to HaRD CCG employed Pharmacists and Medicines Optimisation Technicians. These protocols are produced by the
More informationGuidance on Bulk Prescribing for Care Home Residents
Guidance on Bulk Prescribing for Care Home Residents There are many residents in care homes taking medicines when required, which may present problems for the prescriber in determining the quantity to
More informationSwitch protocol: Insulin pen needles to cost effective brand
Switch protocol: Insulin pen needles to cost effective brand Applies to HaRD CCG employed Pharmacists and Medicines Optimisation Technicians. These protocols are produced by the NY&AWC MM team hosted by
More informationMetformin MR to low cost branded generic (Sukkarto SR) Switch Protocol
Metformin MR to low cost branded generic (Sukkarto SR) Switch Protocol Applies to HaRD CCG employed Pharmacists and Medicines Optimisation Technicians. These protocols are produced by the NY&AWC MM team
More informationADMINISTRATION OF INSULIN
STANDARD OPERATING PROCEDURE ADMINISTRATION OF INSULIN Issue History First issued April 2012 Issue Version Two Purpose of Issue/Description of Change Planned Review Date To promote the safe administration
More informationSwitch protocol: Insulin pen needles to cost effective brand
Switch protocol: Insulin pen needles to cost effective brand Applies to HaRD CCG employed Pharmacists and Medicines Optimisation Technicians. These protocols are produced by the NY&AWC MM team hosted by
More informationTitle of Project: NHS Dumfries & Galloway Respiratory Bundle Asthma: Bronchodilator Overuse Review April 2015
Title of Project: NHS Dumfries & Galloway Respiratory Bundle Asthma: Bronchodilator Overuse Review April 2015 1 Reason for the review Respiratory prescribing is long term and can be costly. Appropriate
More informationMedicines Optimisation Prescribing Audit: Long acting muscarinic antagonist (LAMA ) review
Medicines Optimisation Prescribing Audit: Long acting muscarinic antagonist (LAMA ) review Aim To identify all patients prescribed long acting muscarinic antagonists (LAMAs) and where clinically appropriate
More informationRef. Version Supersedes Approved for Date approved Document Owner N/A MMT 17/01/2017 Lois Taylor. Switching to Alogliptin (Vipidia )
Ref. Version Supersedes Approved for Date approved Document number use by Owner 001 1.0 N/A MMT 17/01/2017 Lois Taylor Aim: Switching to Alogliptin (Vipidia ) To reduce our spend on gliptins (DDP-4 drugs)
More informationNHS Dumfries & Galloway Ferrous Salt Review Protocol November 09
Title of Project: NHS Dumfries & Galloway Ferrous Salt Review Protocol November 09 1 Reason for the review Choice of iron preparation is based on cost and incidence of side effects (BNF). There is little
More informationProScript User Guide. Pharmacy Access Medicines Manager
User Guide Pharmacy Access Medicines Manager Version 3.0.0 Release Date 01/03/2014 Last Reviewed 11/04/2014 Author Rx Systems Service Desk (T): 01923 474 600 Service Desk (E): servicedesk@rxsystems.co.uk
More informationMedicines Optimisation Team Standard Operating Procedure for Audit: High Dose Inhaled Corticosteroids
Cannock Chase Clinical Commissioning Group South East Staffordshire and Seisdon Peninsula Clinical Commissioning Group Stafford and Surrounds Clinical Commissioning Group East Staffordshire Clinical Commissioning
More informationADVANCE PREPARATION OF INSULIN FOR PATIENTS TO ADMINISTER AT HOME
STANDARD OPERATING PROCEDURE ADVANCE PREPARATION OF INSULIN FOR PATIENTS TO ADMINISTER AT HOME First Issued July 08 Issue Version Two Purpose of Issue/Description of Change Planned Review Date To promote
More informationNorth of England Cancer Network. Policies and Procedures. Standards for the Safe Use of Oral Anticancer Medicines
\ North of England Cancer Network Policies and Procedures Standards for the Safe Use of Oral Anticancer Medicines NECN Oral Anticancer medicine Policy version 1.6 Page 1 of 17 Issue Date: Feb 2017 Contents
More informationProduct Cost per Pack Cost per 28 days (assuming 2 sprays od) Flixonase years 50mcg in both nostrils od (increasing to max bd prn)
Protocol for Flixonase to Avamys Nasal Spray Switch May 2010 1. Reason Avamys contains the corticosteroid fluticasone furoate (27.5mcg/spray) and Flixonase nasal spray contains fluticasone propionate (50mcg/spray).
More informationThird party prescription request for Continence and Stoma products. August 2013
Third party prescription request for Continence and Stoma products August 2013 DOCUMENT CONTROL Document Location Copies of this document can be obtained from: Name: Address: Medicines Management Team
More informationSeretide 250mcg/125mcg Evohaler switch to Fostair 100/6 MDI in COPD.
Seretide 250mcg/125mcg Evohaler switch to Fostair 100/6 MDI in COPD. Applies to HaRD CCG employed Pharmacists and Medicines Optimisation Technicians These protocols are produced by the NY&AWC MM team hosted
More informationSCHEDULE 2 THE SERVICES
SCHEDULE 2 THE SERVICES A. Service Specifications Mandatory headings 1 4: mandatory but detail for local determination and agreement Optional headings 5-7: optional to use, detail for local determination
More informationWest Suffolk Clinical Commissioning Group (WSCCG) Safety audit for methotrexate prescribing for patients in primary care
West Suffolk Clinical Commissioning Group (WSCCG) Safety audit for methotrexate prescribing for patients in primary care Year 2013-2014 Safety 100% of patients prescribed oral methotrexate should have
More informationVolume 11; Number 5 February 2017 REVIEW OF GONADOTROPIN RELEASING HORMONE AGONISTS FOR PROSTATE CANCER (REVISED EDITION)
Optum in association with Lincolnshire Clinical Commissioning Groups, Lincolnshire Community Health Services, United Lincolnshire Hospitals Trust and Lincolnshire Partnership Foundation Trust Volume 11;
More informationIntroduction. Guidelines for patient involvement in the administration of insulin under supervision in hospital (Adult patients)
Guidelines for patient involvement in the administration of insulin under supervision in hospital (Adult patients) Introduction This guideline is designed to provide a framework for patients to administer
More informationA three month project September December 2016
Improving Insulin Safety in the Clinical Decision Unit A three month project September December 2016 Sarah Gregory - In-Patient DSN, QEQM Hospital Julie Gammon - Ward Manager, CDU, QEQM Hospital 1 The
More informationAsacol / Mesalazine to Octasa Switch protocol
Asacol / Mesalazine to Octasa Switch protocol Applies to HaRD MMT Technicians, Pharmacists These protocols are produced by the NY&AWC MM team hosted by HaRD CCG for use by their employed MM team members.
More informationRef: E 007. PGEU Response. Consultation on measures for improving the recognition of medical prescriptions issued in another Member State
Ref:11.11.24E 007 PGEU Response Consultation on measures for improving the recognition of medical prescriptions issued in another Member State PGEU The Pharmaceutical Group of the European Union (PGEU)
More informationPHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS
PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS The benefits of prefilled syringes for palliative care from the hospital pharmacy service In
More informationRepeat Dispensing Handbook
Repeat Dispensing Handbook For Sunderland Flow charts and quick reference guides for General Practice and Community Pharmacy No. Introduction 3 Training for Repeat Dispensing 4 Repeat Dispensing Champions
More informationSOMATROPIN ( Genotropin, Humatrope, Norditropin,
Shared Care Guidelines DRUG: SOMATROPIN ( Genotropin, Humatrope, Norditropin, Saizen and Omnitrope ) (Adults) Introduction: Indication: Growth hormone deficiency in adults Dosage & administration: 150-300
More informationmedicines_management/correspondence/pathway-for-the-managed- Access-of-FreeStyle-Libre.
Pathway for the Managed Access of FreeStyle Libre (Flash Glucose monitoring) for Adults and Children in the care of Trust Specialist Diabetes Clinics in Northern Ireland www.hscboard.hscni.net/download/publications/pharmacy_and_
More informationGENERIC MEDICINES (Non-Innovator Brand) PRESCRIBING POLICY
GENERIC MEDICINES (Non-Innovator Brand) PRESCRIBING POLICY First issued by/date Issue Version Purpose of Issue/Description of Change Planned Review Date August 2018 1.0 Promoting generic prescribing whenever
More informationMedicines Optimisation Team Standard Operating procedure for Alogliptin Audit:
Medicines Optimisation Team Standard Operating procedure for Alogliptin Audit: To review type 2 diabetic patients prescribed dipedtidylpeptidase-4 (DPP-4) inhibitors (linagliptin (Trajenta, saxagliptin
More informationPatient Group Direction for the Supply of Orlistat (Xenical) from Designated Community Pharmacies
Patient Group Direction for the Supply of Orlistat (Xenical) from Designated Community Pharmacies Written by: Sheila Brown, Prescribing Adviser Date: September 2006 Reviewed by: Date: Ratified by: East
More informationAssistant Practitioner and Health Care Assistants Administration of Insulin, via Pen device, by Delegation Training and competency Toolkit
Assistant Practitioner and Health Care Assistants Administration of Insulin, via Pen device, by Delegation Training and competency Toolkit Document Summary The purpose of this policy is to guide and promote
More informationTemplate Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices
Name of Dental Practice : Objectives To ensure implementation of the regulations and guidance on safe and secure handling of midazolam and other controlled drugs (CDs) Scope To cover all aspects of obtaining
More informationNHS Circular: PCA(M)(2011)4 abcdefghijklmnopqrstu TREATMENT OF ERECTILE DYSFUNCTION: PATIENTS WITH SEVERE DISTRESS. Summary
Directorate for Health and Social Care Integration Primary Care NHS Circular: abcdefghijklmnopqrstu Dear Colleague LIST OF DRUGS SUBJECT TO PRESCRIBING TREATMENT OF ERECTILE DYSFUNCTION: PATIENTS WITH
More informationBrook Green Centre for Learning. Policy and Guidance for Supporting Pupils with Medical Needs
Brook Green Centre for Learning Policy and Guidance for Supporting Pupils with Medical Needs This document was written in line with recommendations made in the DfE s information pack Supporting Pupils
More informationSunderland Diabetes Network - Recommendations for safe prescribing of insulin.
Sunderland Diabetes Network - Recommendations for safe prescribing of insulin. Note: High strength insulins and biosimilar insulins are for specialist initiation only. They should not be initiated in primary
More informationSunderland Diabetes Network - Recommendations for safe prescribing of insulin.
Sunderland Diabetes Network - Recommendations for safe prescribing of insulin. Note: High strength insulins and biosimilar insulins are for specialist initiation only. They should not be initiated in primary
More informationLocally Enhanced Service for Stopping Smoking
NHS Devon Locally Enhanced Service for Stopping Smoking This Local Enhanced Service (LES) Specification details the agreement between Devon PCT (the commissioner) and community pharmacies (the service
More informationEmis Web Technical Guidance
Emis Web Technical Guidance Updated February 2018 1 Dementia 18-19 Technical Solution Emis Web Implementation Guide Summary A resource to provide system support to clinicians and CCGs to: Data cleansing
More informationDERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) JAPC Briefing FreeStyle Libre
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) JAPC Briefing FreeStyle Libre JAPC has classified Freestyle Libre as BROWN after diabetes consultant/specialist initiation within a Derbyshire diabetes
More informationURGENT MEDICINE RECALL
Wednesday 7 th September 2016 URGENT MEDICINE RECALL GlucaGen HypoKit (glucagon (rys) as HCl 1 mg (1 IU) powder vial with 1 ml, prefilled solvent syringe); AUST R 47105 Batch numbers: FS6X465, FS6X536,
More information1. Intrathecal must never be abbreviated to IT on a prescription form True / False
Appendix 1: Intrathecal SACT Assessment Questions Core General Questions must be completed by all staff. 1. Intrathecal must never be abbreviated to IT on a prescription form 2. Intrathecal SACT must be
More informationA patient guide to the use of insulin for diabetes
A patient guide to the use of insulin for diabetes Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm
More informationInsulin Safety. Tracey Roe DSN SSOT partnership trust
Insulin Safety Tracey Roe DSN SSOT partnership trust Insulin Type 1 Type 2 when oral therapies are not tolerated or contra/indicated Post MI Intercurrent illness Pre/peri/post op Gestational diabetes Painful
More informationMedsCheck Reviews. Ontario
MedsCheck Reviews Ontario Contents Configuration... 1 Configuring Electronic Signatures... 1 Configuring Electronic MedsCheck Reviews... 2 Creating an ODB MedsCheck Consent Record... 3 Electronic MedsCheck
More informationPATIENT GROUP DIRECTION PROCEDURE
PATIENT GROUP DIRECTION PROCEDURE Date approved 2 October 2015 Version 3 Approved by Yvette Oade, Chief Medical Officer Procedure Lead Clinical Governance Lead - Medicines Management Procedure Author Karen
More informationLocal Improvement Scheme (LIS) 2016/17 Local Service for Dementia Care in East Lancashire GP Practices
Local Improvement Scheme (LIS) 2016/17 Local Service for Dementia Care in East Lancashire GP Practices CONTENT Page number 1. Introduction 2 2. 5 key elements of the Dementia LIS 3 Practice Awareness Practice
More informationCare Homes - Homely Remedies Protocol
Care Homes - Homely Remedies Protocol A homely remedy is a medicine for the short-term treatment of a minor ailment, such as indigestion, a cough, mild to moderate pain or constipation, and can be obtained
More informationADMELOG, NOVOLIN, NOVOLOG, and FIASP
ADMELOG, NOVOLIN, NOVOLOG, and FIASP Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy
More informationPolypharmacy and Deprescribing. A special report on views from the PrescQIPP landscape review
Polypharmacy and Deprescribing A special report on views from the PrescQIPP landscape review Introduction and background In recent years, we have seen the emergence of an international discussion around
More informationTemporary interruption in supply of APIDRA (insulin glulisine) - OPTISET and SOLOSTAR prefilled pens and CLIKSTAR reusable cartridges.
September 2011 Dear Health Care Professional, Temporary interruption in supply of APIDRA (insulin glulisine) - OPTISET and SOLOSTAR prefilled pens and CLIKSTAR reusable cartridges. We would like to inform
More informationHomely Remedies Guidance for Care Homes
Homely Remedies Guidance for Care Homes What is a homely remedy? Homely or household remedy is another name for a non-prescription medicine which is used in a care home for the short term management of
More informationNHS Bowel Cancer Screening Programme
NHS Bowel Cancer Screening Programme Wolverhampton Bowel Cancer Screening Centre Annual Report April 2016 to March 2017 @RWT_NHS Introduction Bowel cancer is the fourth most common cancer in the UK after
More informationشءءذص Primary Care Respiratory. Tools to help you stratify people with asthma who should be offered a priority review
م م مء مكى مس Tools to help you stratify people with asthma who should be offered a priority review explores how to help stratify people with asthma providing م ف م خ links to XML files you can access
More informationPlease see the attached drug alert for onward transmission as below.
Chief Medical Officer Directorate Pharmacy and Medicines Division T: 0131-244 2528 E: irene.fazakerley@gov.scot IMMEDIATE MESSAGE TO: 1. Directors of Pharmacy 2. Medical Directors NHS Boards 18 April 2018
More informationBRISTOL-MYERS SQUIBB and ASTRAZENECA v SANOFI
CASE AUTH/2638/9/13 and AUTH/2639/9/13 BRISTOL-MYERS SQUIBB and ASTRAZENECA v SANOFI Promotion of Lyxumia Bristol-Myers Squibb and AstraZeneca jointly complained about cost comparison claims in a Lyxumia
More informationRaising the Standard
DIABETES ACTION PLAN (Editable document) Directions: 1. To input data, click on the first blank line, type in information 2. Use tab key to advance to the next field 3. Check mark fields, use tab to advance
More informationReview of Oral Nutritional Supplement (ONS) prescribing
Applies to Review of Oral Nutritional Supplement (ONS) prescribing HaRD CCG employed Pharmacists and Medicines Optimisation Technicians. These protocols are produced by the NY&AWC MM team hosted by HaRD
More informationManagement of Migraine
Title of Project: NHS Dumfries & Galloway June 2013 Management of Migraine 1 Reason for the review SIGN 107 Diagnosis and management of headache in adults, advises that patients with migraine and those
More informationPROCEDURE FOR BLOOD GLUCOSE MONITORING
PROCEDURE FOR BLOOD GLUCOSE MONITORING First Issued Issue Version Two Purpose of Issue/Description of Change Planned Review Date To promote safe and effective blood glucose monitoring using Trust equipment
More informationA Suite of Enhanced Services for. Prudent Structured Care for Adults with Type 2 Diabetes
An Enhanced Service for Prudent Structured Care for Adults with Type 2 Diabetes Page 1 A Suite of Enhanced Services for Prudent Structured Care for Adults with Type 2 Diabetes 1. Introduction All practices
More informationthe person is intolerant of either metformin or a sulphonylurea, or treatment with metformin or a sulphonylurea is contraindicated, and
Exenatide (Byetta) and Liraglutide (Victoza) prescribing guidance: Notes for initiation in primary care These incretin mimetics are given by subcutaneous injection once or twice daily. They have similar
More informationManaging Type 2 Diabetes in Frailty within Primary Care
Managing Type 2 Diabetes in Frailty within Primary Care Author Medicines Management Pharmacist Version 1.0 Written: May 2017 Next review: May 2018 Approved by IESCCG Workstream Date approved 27/6/17 Contents
More informationCare homes - Homely remedies
Bulletin 72 August 2014 Community Interest Company Care homes - Homely remedies Care home staff have a recognised duty of care to be able to respond to minor symptoms experienced by residents. A homely
More informationGLUTEN-FREE FOOD SCHEME. Information Pack
GLUTEN-FREE FOOD SCHEME Information Pack The Tayside Gluten-Free Food Scheme is part of the Scottish Gluten-Free Food Service. There are variations from the Scottish Service and more information can be
More informationCommunity Pharmacy Asthma Audit 2016/17. Contents
Community Pharmacy Contents Community Pharmacy... 1 Executive Summary... 2 Introduction... 4 Background... 4 Method... 5 Results... 5 Section One: Community Pharmacy Guidelines Awareness and Training...
More informationIntegrated Community Diabetes Services (ICDS) GP Referral Guide Version 3 - October 2014
Integrated Community Diabetes Services (ICDS) GP Referral Guide Version 3 - October 2014 Introduction The Integrated Community Diabetes Service (ICDS) will deliver high quality care to individuals who
More informationFREEDOM OF INFORMATION ACT 2000 Dudley CCG: Prescribing of Antibiotics Ref: RFI0861
Freedom of Information Team Dudley CCG 17 November 2017 2nd Floor, Brierley Hill Health and Social Care Centre Venture Way Brierley Hill DY5 1RU FREEDOM OF INFORMATION ACT 2000 Dudley CCG: Prescribing
More informationPatient Group Direction for the Supply of Varenicline (Champix ) by Authorised Community Pharmacists
Patient Group Direction for the Supply of Varenicline (Champix ) This Patient Group Direction (PGD) is a specific written instruction for the supply of varenicline to groups of patients who may not be
More informationPatient Safety Alert NPSA/2011/PSA003 The adult patient s passport to safer use of insulin
Patient Safety Alert NPSA/2011/PSA003 The adult patient s passport to safer use of insulin March 2011 Supporting Information Contents Page 1. About this document 2 2. Background 2 3. Scope 3 4. Review
More informationACE Programme SOMERSET INTEGRATED LUNG CANCER PATHWAY. Phases One and Two Final Report
ACE Programme SOMERSET INTEGRATED LUNG CANCER PATHWAY Phases One and Two Final Report July 2017 Introduction This paper presents the learning and actions that have been generated from phase One and Two
More informationAPIDRA (insulin glulisine) injection vial APIDRA SOLOSTAR (insulin glulisine) subcutaneous solution pen-injector
APIDRA SOLOSTAR (insulin glulisine) subcutaneous solution pen-injector Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific
More informationPharmacy Manual. Cambridge University Hospitals NHS Foundation Trust & University of Cambridge
Page 1 of 11 Pharmacy Manual Trial Title: PRedicting Outcomes For Crohn s disease using a molecular biomarker (PROFILE) trial EudraCT Number: N/A (non-ctimp study) ISRCTN: 11808228 REC Reference: 17/EE/0382
More informationCETUXIMAB FOR THE FIRST LINE TREATMENT OF METASTATIC COLORECTAL CANCER (MCRC)
CETUXIMAB FOR THE FIRST LINE TREATMENT OF METASTATIC COLORECTAL CANCER (MCRC) 1. BACKGROUND submitted evidence to NICE on the 2 nd cetuximab in the treatment of mcrc. May 2008 for the appraisal of The
More informationProcedure for the prescribing and administration of insulin
Procedure for the prescribing and administration of insulin Author: Lilian Baxendale and Heather Beadle Designation: Clinical Governance Pharmacists Version: Version 3 Date: December 2016 Date Approved:
More informationGuidelines for Product Recall or Withdrawal
REPUBLIC OF KENYA PHARMACY AND POISONS BOARD Guidelines for Product Recall or Withdrawal Edition 1 Date of release for publication June 2006 Date of implementation June 2006 This document has been prepared
More informationStandard Reporting Template
Appendix Seven Annual Report Template Standard Reporting Template London Region [North Central & East/North West/South London] Area Team 2017/2018 Patient Participation Enhanced Service Reporting Template
More informationPRSB e-discharge summary phase 2 Medications and medical devices information model
PRSB e-discharge summary phase 2 Medications and medical devices information model Purpose This paper provides an information model for medications and medical devices. It is based on the discharge summary
More informationPriorities Advisory Committee
Insulin degludec (Tresiba ) PAC - Insulin degludec (Tresiba ) 2.1 The East of England Priorities Advisory Committee A function of GUIDANCE STATEMENT PAC Recommendations 1. Insulin degludec is NOT recommended
More informationPRESCRIBING INCENTIVE SCHEME 2018/19
PRESCRIBING INCENTIVE SCHEME 2018/19 Summary Harrogate and Rural District CCG is continuing to offer a prescribing incentive scheme to all its member NHS GP practices as encouragement and reward to improve
More informationStoma Additional Products Savings Guidance
Stoma Additional Products Savings Guidance Stoma care additional products (also known as ancillary products) are prescribed for individual patients to help prevent sore skin and other problems developing
More informationNew regulatory requirements DPCS Regulations 2017
New regulatory requirements DPCS Regulations 2017 Prescribers and pharmacists May 2017 Table of Contents Explanatory notes... 1 Clarifying the meaning of key terms... 1 Chart instructions and prescriptions...
More informationOpioid Management Change Package 2017/2018
Opioid Management Change Package 2017/2018 Opioid Prescribing and Management Overall 100% 80% 60% 40% 20% 0% 01/07/2016 01/08/2016 01/09/2016 01/10/2016 01/11/2016 01/12/2016 01/01/2017 01/02/2017 01/03/2017
More informationIntroduction. Methods
A New Perspective On A Difficult Discharge: Ensuring the newly diagnosed diabetic patient gets the proper prescriptions when it s time to go home. Ashley Carter, PGY 3 Introduction A hospitalized patient
More informationTHIS IS A PATIENT HAND HELD DOCUMENT CARE PATHWAY FOR MANAGEMENT OF INITIATION OF INSULIN
Worcestershire Trusts Please attach patient sticker here or record: GP Name: Consultant:. Ward: THIS IS A PATIENT HAND HELD DOCUMENT CARE PATHWAY FOR MANAGEMENT OF INITIATION OF INSULIN This Care Pathway
More informationMedicines Management Team Prescription Clerk Training Event
Medicines Management Team Prescription Clerk Training Event Sanjeev Sharma and Marie M c Ilwain September 2017 Introductions Medicines Waste Question-what happens to unused medicines that are returned
More informationEssential Shared Care Agreement (South Staffordshire): Aciclovir Administration in the Community
E088 Essential Shared Care Agreement (South Staffordshire): Aciclovir Administration in the Community Patient s name: DOB NHS Number Patient s address: Consultant Note: Shared care agreement sets out a
More informationPOLICY FOR THE SAFE USE OF ORAL METHOTREXATE IN SECONDARY CARE. September 2011
POLICY FOR THE SAFE USE OF ORAL METHOTREXATE IN SECONDARY CARE September 2011 WHSCT Policy for the safe use of oral methotrexate in secondary care Page 1 of 8 Policy Title Policy for the safe use of oral
More informationPolicy for the provision of gluten-free food in East and North Hertfordshire
Policy for the provision of gluten-free food in East and North Hertfordshire Page 1 of 13 DOCUMENT CONTROL SHEET Document Owner: Document Author(s): Director of Commissioning Stacey Golding, Senior Pharmaceutical
More informationGood Practice Guidance on Homely Remedy Policy For Adult Service Users in Care Homes
Good Practice Guidance on Homely Remedy Policy For Adult Service Users in Care Homes This good practice guidance is intended to be used as a framework for care home managers to adapt when writing their
More informationAripiprazole Long-Acting Injection (Abilify Maintena ) Guidelines for Prescribing and Administration (Version 3 August 2014)
1. Key Points. Aripiprazole Long-Acting Injection (Abilify Maintena ) Guidelines for Prescribing and Administration (Version 3 August 2014) 1.1 Aripiprazole long acting injection (LAI) is licensed / indicated
More informationDiabetes Emergency Caesarean section or other unplanned surgery (GL822)
Diabetes Emergency Caesarean section or other unplanned surgery (GL822) i.e. insulin dependent diabetic having unplanned surgery e.g. a diabetic woman with pre-labour SROM prior to elective Caesarean section.
More informationAn overview of Patient Group Directions (PGDs)
An overview of Patient Group Directions (PGDs) The first stop for professional medicines advice Jo Jenkins Specialist Pharmacist Patient Group Directions SPS February 2018 Scope of SPS PGD service where
More informationMedication Safety. Patient Safety. Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016
Medication Safety Patient Safety Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016 1 The patient journey Admission Ward Transfer Ward stay Discharge Medication storage and supply
More informationContinuous Subcutaneous Insulin Infusion (CSII) pump therapy
Page 1 of 14 Continuous Subcutaneous Insulin Infusion (CSII) pump therapy Introduction This booklet has been compiled by the Insulin Pump Therapy Team to standardise the information given to patients on
More informationDIABETES POLICY. Templeton Primary School strives to ensure the safety and wellbeing of children who are diagnosed with diabetes, and committed to:
DIABETES POLICY Rationale Templeton Primary School strives to ensure the safety and wellbeing of children who are diagnosed with diabetes, and committed to: providing a safe and healthy environment in
More informationCommissioning Statement. Flash Glucose Monitoring system (FreeStyle Libre ) March 2018
Technology Commissioning Statement Flash Glucose Monitoring system (FreeStyle Libre ) March 2018 FreeStyle Libre (Abbott) Flash Glucose Monitoring System for use in adults, young people and children. Recommendation
More information